In vivo characteristics of low molecular weight copoly(L-lactic acid/glycolic acid) formulations with controlled release of luteinizing hormone-releasing hormone agonist
- 1 July 1989
- journal article
- Published by Elsevier in Journal of Controlled Release
- Vol. 9 (2) , 111-122
- https://doi.org/10.1016/0168-3659(89)90002-3
Abstract
No abstract availableThis publication has 26 references indexed in Scilit:
- Biodegradable hollow fibres for the controlled release of drugsBiomaterials, 1988
- Effect of drug–vinyl copolymer delivery composites on the rat prostateJournal of Biomedical Materials Research, 1985
- Preliminary report on use of depot formulation of LHRH analogue ICI 118630 (Zoladex) in patients with prostatic cancer.BMJ, 1985
- Preparation and evaluation in vitro and in vivo of polylactic acid microspheres containing dibucaine.CHEMICAL & PHARMACEUTICAL BULLETIN, 1982
- Influence of physicochemical properties of polylactic acid on the characteristics and in vitro release patterns of polylactic acid microspheres containing local anesthetics.CHEMICAL & PHARMACEUTICAL BULLETIN, 1982
- Calibration in gel permeation chromatography: primary, universal and empirical methodsPolymer, 1981
- Biodegradable systems for the sustained release of fertility-regulating agentsJournal of Steroid Biochemistry, 1979
- Sustained release of an antimalarial drug using a copolymer of glycolic/lactic acidLife Sciences, 1976
- Lactic/glycolic acid polymers as narcotic antagonist delivery systemsLife Sciences, 1975
- Long-acting delivery systems for narcotic antagonists. 1Journal of Medicinal Chemistry, 1973